Microtubule/Tubulin
Microtubule is the cylindrical and filamentous structure that required for cell shape, migration, cilia and flagella mobility etc. Tubulin is the major component of microtubules.
Products for Microtubule/Tubulin
- Cat.No. Product Name Information
-
GC49736
10-acetyl Docetaxel
PNU 101383, 10-acetyl Taxotere
10-acetyl Docetaxel (10-Acetyl docetaxel) is an analog of Docetaxel, with anticancer activity. Docetaxel is a microtubule disassembly inhibitor, with antimitotic activity. -
GC12954
10-DAB (10-Deacetylbaccatin)
NSC 251677
An inhibitor of microtubule assembly -
GC35044
10-Deacetyl-7-xylosyl paclitaxel
10-Deacetyl-7-xylosyl paclitaxel is a Paclitaxel (a microtubule stabilizing agent; enhances tubulin polymerization) derivative with improved pharmacological features.
-
GC35045
10-Oxo Docetaxel
A docetaxel degradation product
-
GC15084
2-Methoxyestradiol (2-MeOE2)
2Hydroxyestradiol 2methyl ether, 2ME2, NSC 659853, Panzem
2-Methoxyestradiol (2-MeOE2/2-Me) is an HIF-1α inhibitor. -
GC17271
4'-Demethylepipodophyllotoxin
(-)-4′-Demethylepipodophyllotoxin
An inhibitor of tubulin polymerization -
GC63958
6α-Hydroxy Paclitaxel-d5
6α-Hydroxy Paclitaxel-d5 is the deuterium labeled 6α-Hydroxy paclitaxel. 6α-Hydroxy paclitaxel is a primary metabolite of Paclitaxel. 6α-Hydroxy paclitaxel retains a time-dependent effect on organic anion-transporting polypeptides 1B1/SLCO1B1 (OATP1B1) with similar inhibition potency to Paclitaxel, whereas it no longer showed time-dependent inhibition of OATP1B3. 6α-Hydroxy paclitaxel can be used for the research of cancer.
-
GC35188
7-Epi-10-oxo-docetaxel
7-Epi-10-oxo-docetaxel (Docetaxel Impurity 2) is a impurity of docetaxel detected by high performance liquid chromatography (HPLC).
-
GC35189
7-Epi-docetaxel
7-Epi-10-oxo-docetaxel (Docetaxel Impurity C; 7-Epitaxotere) is a impurity of docetaxel.
-
GN10625
7-Epitaxol
7-epi Taxol
-
GC42610
7-hydroxy Pestalotin
LL-P880β
7-hydroxy Pestalotin is a fungal metabolite originally isolated from Penicillium. -
GC35197
7-xylosyltaxol
A taxane with microtubule disruptor and anticancer activities
-
GC15875
ABT-751 (E7010)
ABT-751 (E7010)(E 7010) is a novel bioavailable tubulin-binding and antimitotic sulfonamide agent with IC50 of about 1.5 and 3.4 μM in neuroblastoma and non-neuroblastoma cell lines, respectively.
-
GC68614
AcLys-PABC-VC-Aur0101
AcLys-PABC-VC-Aur0101 is part of an antibody-conjugated active molecule (anti-CXCR4 ADC). It is composed of Aur0101 (a type of auristatin microtubule inhibitor) and a degradable linker AcLys-PABC-VC.
-
GC64698
AM-5308
AM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13).
-
GC65578
Aminobenzenesulfonic auristatin E TFA
Aminobenzenesulfonic auristatin E TFA is a drug-linker conjugate for ADC. Aminobenzenesulfonic auristatin E TFA has potent antitumor activity by using Auristatin E (a cytotoxic tubulin modifier), linked via the ADC linker Aminobenzenesulfonic.
-
GC33370
Amphethinile (Amphetinile)
Amphetinile; CRC 82-07
Amphethinile (Amphetinile) is an anti-tubulin agent. The affinity constant for the association (Ka) of Amphethinile (Amphetinile) with tubulin is 1.3 μM. -
GC64273
AMXI-5001
AMXI-5001 is a potent, orally active, and dual parp1/2 and microtubule polymerization inhibitor. MXI-5001 exhibits selective antitumor cytotoxicity across a wide variety of human cancer cells with much lower IC50s than existing clinical PARP1/2 inhibitors. AMXI-5001 induces complete regression of established tumors, including exceedingly large tumors.
-
GC67900
AMXI-5001 hydrochloride
-
GC11947
Ansamitocin P-3
Antibiotic C-15003P3, Maytansinol butyrate
A microtubule depolymerizing agent -
GC66198
Anti-α-Tubulin Antibody, AF555 conjugate
Anti-α-Tubulin Antibody, AF555 conjugate is a conjugate of mouse anti-α-tubulin monoclonal antibody and the red fluorescent dye Alexa Fluor 555. Anti-α-Tubulin Antibody, AF555 conjugate can be used for the detection of tubulin (Ex/Em: 554/567 nm).
-
GC68024
Antiproliferative agent-14
-
GC35429
Auristatin E
Auristatin E is a cytotoxic tubulin modifier with potent and selective antitumor activity; MMAE analog and cytotoxin in Antibody-drug conjugates. Auristatin E inhibits cell division by blocking the polymerisation of tubulin.
-
GC35430
Auristatin F
Auristatin F is a potent cytotoxin. Auristatin F, a potent microtubule inhibitor and vascular damaging agent (VDA), can be used in antibody-drug conjugates (ADC).
-
GC63663
Avanbulin
BAL27862
Avanbulin (BAL27862) is a potent, Colchicine site-binding, tubulin assembly inhibitor. Avanbulin inhibits tubulin assembly at 37 °C with an IC50 of 1.4 μM. Avanbulin binds to tubulin with an apparent Kd value of 244 nM. Avanbulin can be used for the research of cancer and cell division. -
GC60620
Batabulin
Batabulin (T138067) is an antitumor agent, which binds covalently and selectively to a subset of the β-tubulin isotypes, thereby disrupting microtubule polymerization. Batabulin affects cell morphology and leads to cell-cycle arrest ultimately induces apoptotic cell death.
-
GC60621
Batabulin sodium
T138067
An inhibitor of tubulin polymerization -
GC42942
bis-ANS (potassium salt)
4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid
bis-ANS (potassium salt) is a fluorescent probe of hydrophobic protein. -
GC34102
BNC105
BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.
-
GC39483
BO-264
BO-264 is a highly potent and orally active transforming acidic coiled-coil 3 (TACC3) inhibitor with an IC50 of 188 nM and a Kd of 1.5 nM. BO-264 specifically blocks the function of FGFR3-TACC3 fusion protein. BO-264 induces spindle assembly checkpoint (SAC)-dependent mitotic arrest, DNA damage and apoptosis. BO-264 has broad-spectrum antitumor activity.
-
GC48901
BRD9876
An Eg5 inhibitor
-
GC33149
BTB-1
NSC 156750, NSC 658180
A reversible Kif18A inhibitor -
GC11765
Cabazitaxel
TXD 258, XRP 6258
Microtubule associated inhibitor -
GC65575
Cabazitaxel-d6
Cabazitaxel-d6 (XRP6258-d6) is the deuterium labeled Cabazitaxel. Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity.
-
GC45395
Cabazitaxel-d9
XRP6258-d9; RPR-116258A-d9; taxoid XRP6258-d9
Cabazitaxel-d9 is deuterium labeled Cabazitaxel. Cabazitaxel is a semi-synthetic derivative of the natural taxoid 10-deacetylbaccatin III with potential antineoplastic activity. -
GC74519
Cantuzumab ravtansine
IMGN242; huC242-DM4
Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4 (DM4 ). -
GC40890
CAY10701
CAY10701 is a 7-deazahypoxanthine analog that prevents microtubule formation, blocking the proliferation of HeLa and MCF-7 cells (GI50s = 22 and 38 nM, respectively).
-
GC33300
CCB02
CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity. CCB02 shows no inhibition on the cell cycle- and centrosome-related kinases, or the phosphorylation status of Aurora A, Plk1, Plk2, CDK2, and CHK1.
-
GN10780
Cephalomannine
NSC 318735
-
GC35654
Ceratamine A
Ceratamine A is an antimitotic heterocyclic alkaloid isolated from the marine sponge Pseudoceratina sp., acts as a microtubule-stabilizing agent. Ceratamine A exhibits cytotoxicity against human cancer cell lines.
-
GC11905
Cevipabulin
TTI-237
Anti-microtubule agent -
GC35659
Cevipabulin fumarate
TTI-237 fumarate
Cevipabulin fumarate (TTI-237 fumarate) is an oral, microtubule-active, antitumor compound and inhibits the binding of [3H]NSC 49842 to tubulin, with an IC50 of 18-40 nM for cytotoxicity in human tumor cell line. -
GC15894
CK-636
CK-0944636
Arp2/3 complex inhibitor -
GC74600
Cofetuzumab pelidotin
PF-06647020; ABBV-647; h6M24-vc0101
Cofetuzumab pelidotin (PF-06647020) is a PTK7-targeting ADC comprising a humanized anti-PTK7 mAb joined to an auristatin microtubule inhibitor payload, auristatin-0101, by a cleavable valine-citrulline (vc)-based linker. -
GC40664
Colcemid
Demecolcine, NSC 3096
Colcemid is a cytoskeletal inhibitor that induces mitotic arrest in the G2/M phase or meiotic arrest in the vesicle rupture (GVBD) phase in mammalian cells or oocytes, respectively. -
GC13261
Colchicine
Colchicine, an orally active alkaloid, disrupts cytoskeletal function by inhibiting the polymerization of β-tubulin into microtubules, with an IC50 of 3 nM.
-
GC43300
Combretastatin A1
CA1
Combretastatin A1 is a cis-stilbene originally isolated from C. -
GC17631
Combretastatin A4
CA4, Combretastatin A4, CRC 8709
tubulin polymerization inhibitor -
GC43315
Corynecin IV
Corynecin IV is a chloramphenicol-like bacterial metabolite originally isolated from Corynebacterium.
-
GC40663
Corynecin V
Corynecin V is a chloramphenicol-like bacterial metabolite originally isolated from Corynebacterium.
-
GC19112
Crolibulin
EPC2407
Crolibulin is a small molecule tubulin polymerization inhibitor. -
GC40482
Curvulin
Curvulin is a phytotoxin first isolated from several species of the mold Curvularia.
-
GC11252
CW069
allosteric inhibitor of HSET, selective
-
GC35789
Cys-mcMMAD
Cys-mcMMAD is a drug-linker conjugate for ADC. MMAD is a potent tubulin inhibitor.
-
GC68929
Cys-McMMAF
"Cys-McMMAF" is the payload released by "AlMcMMAF", a humanized A1 antibody that targets 5T4 and is coupled to microtubule-disrupting MMAF via a maleimide linker. Cys-McMMAF has anti-tumor effects in two mouse models of cancer (H1975 and MDA-MB-361-DYT2).
-
GC11383
CYT997 (Lexibulin)
Lexibulin
CYT997 (Lexibulin) (CYT-997) is a potent and orally active tubulin polymerisation inhibitor with IC50s of 10-100 nM in cancer cell lines; with potent cytotoxic and vascular disrupting activity in vitro and in vivo. CYT997 (Lexibulin) induces cell apoptosis and induces mitochondrial ROS generation in GC cells. -
GC12384
D-64131
D 64131;D64131
An inhibitor of tubulin polymerization -
GC35797
D8-MMAD
-
GC35798
D8-MMAF
Monomethylauristatin F D8
D8-MMAF hydrochloride is a deuterated form of MMAF hydrochloride. MMAF Hydrochloride, a potent tubulin polymerization inhibitor, is used as a antitumor agent and a cytotoxic component of antibody-drug conjugates (ADCs). -
GC35799
D8-MMAF hydrochloride
-
GC74061
DBM-C5-VC-PAB-MMAE
DBM-C5-VC-PAB-MMAE (Compound 3a) is a Drug-Linker conjugate for ADC.
-
GC39486
DCLK1-IN-1
DCLK1-IN-1 is a highly selective inhibitor of DCLK1 and DCLK2 with IC50 values of 9.5nM and 31nM respectively in the KINOMEscan binding assay, and IC50 values of 57nM and 103nM respectively in the ATP kinase assay.
-
GN10426
Deacetyltaxol
10-DAP, 10-Deacetyltaxol
-
GC41304
Deoxybrevianamide E
Deoxybrevianamide E is an alkaloid fungal metabolite that has been found in Aspergillus.
-
GC38564
Deoxypodophyllotoxin
Anthricin, (-)-Deoxypodophyllotoxin, 4-Deoxypodophyllotoxin, DPT, RD4-6266
Deoxypodophyllotoxin (DPT), a derivative of podophyllotoxin, is a lignan with potent antimitotic, anti-inflammatory and antiviral properties isolated from rhizomes of Sinopodophullumhexandrum (Berberidaceae). -
GC43469
Diminutol
NG72
Diminutol is a cell-permeable purine derivative that inhibits the NADP-dependent oxidoreductase, NQO1 (Ki = 1.72 μM), to destabilize microtubules and disrupt mitosis. -
GC60143
DM3
Maytansinoid DM3
DM3 (Maytansinoid DM3) is a maytansine analog bearing disulfide or thiol groups and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs). -
GC38355
DM3-SMe
DM3-SMe is a maytansine derivative and a tubulin inhibitor, and is a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM3-SMe shows highly cytotoxic activity in vitro with an IC50 of 0.0011 nM.
-
GC32810
DM4
DM4 is is an antitubulin agent that inhibit cell division. DM4 can be used in the preparation of antibody drug conjugate.
-
GC38468
DM4-SMe
DM4-SMe is a metabolite of antibody-maytansin conjugates (AMCs) and a tubulin inhibitor, and also a cytotoxic moiety of antibody-drug conjugates (ADCs), which can be linked to antibody through disulfide bond or stable thioether bond. DM4-SMe inhibits KB cells with an IC50 of 0.026 nM.
-
GC38460
DM4-SPDP
DM4-SPDP is a drug-linker conjugate composed of a potent antitubulin agent DM4 and a linker SMCC to make antibody drug conjugate. SPDP is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls.
-
GC16684
Docetaxel
Docetaxel is a taxane class of anti-mitotic chemotherapeutic agents with an IC50 of 0.2 µM.
-
GC48968
Docetaxel (hydrate)
DTX, NSC 628503, RP 56976, Taxotel
An analog of taxol with antitumor properties
-
GC12550
Docetaxel Trihydrate
-
GC16273
Dolastatin 10
DLS 10; NSC 376128
Antitumor agent -
GC10557
Dolastatin 10 trifluoroacetate
Antitumor agent
-
GA21397
Dolastatin 15
NSC 617668
Dolastatin 15 originally isolated from the sea hare Dolabella auricularia belongs to a family of antimitotic and antineoplastic depsipeptides inducing apoptosis in various malignant cell types. It was shown to inhibit the growth of the P388 lymphocytic leukemia cell line efficiently, with an ED?? value of 2.4 ng/mL. -
GC73441
EAPB 02303
EAPB 02303 is a microtubule-disrupting agent and inhibitor.
-
GC16827
ELR510444
Novel microtubule disruptor
-
GC33125
Entasobulin
Entasobulin is a β-tubulin polymerization inhibitor with potential anticancer activity.
-
GC11202
Epothilone A
Epo A
Microtubule stabilizing macrolide -
GC17240
Epothilone B (EPO906, Patupilone)
Epo B
Epothilone B (EPO906, Patupilone) is a microtubule stabilizer with a Ki of 0.71μM. -
GC17440
Epothilone D
Desoxyepothilone B, NSC 73147
A microtubule-stabilizing agent -
GC72977
Epothilone F
Epothilone F is a Microtubule/Tubulin-stabilizing agent with anti-tumor activity.
-
GC74126
ER-076349
ER-076349 is an inhibitor of tubulin polymerization, induces G2-M cell cycle arrest, and disrupts mitotic spindles.
-
GC14354
Eribulin
synthetic analogue of halichondrin B
-
GC12483
Eribulin mesylate
synthetic analogue of halichondrin B
-
GC63845
Eribulin-d3 mesylate
Eribulin-d3 mesylate is a deuterium labeled Eribulin mesylate. Eribulin mesylate is a microtubule targeting agent that is used for the research of cancer.
-
GC67333
Estramustine
Estramustine is an antineoplastic agent. Estramustine depolymerizes microtnbules by binding to tubulin 1, exhibits antimitotic activity with an IC50 value of ~16 μM for mitosis of DU 145 cells. Estramustine blocks cells at mitosis in prostate tumor xenografts.
-
GC32816
Estramustine phosphate sodium
Ro 21-8837/001
A derivative of estradiol that destabilizes microtubules -
GC73543
FC-116
FC-11 is a Tubulin inhibitor that effectively inhibits tumor growth in mice.
-
GC12319
Ferulenol
antimycobacterial activity and stimulates tubulin polymerization
-
GC13210
Flubendazole
NSC 313680, R-17889, R-17899
Autophagy activator -
GC16727
Flutax 1
A fluorescent taxol derivative used for direct imaging of the microtubule cytoskeleton
-
GC50397
Flutax 2
Green fluorescent taxol derivative; binds microtubules
-
GC66242
Flutax-2 (5/6-mixture)
Flutax-2 (5/6-mixture) is an active fluorescent derivative of Taxol. Flutax-2 (5/6-mixture) binds to polymerized α,β-tubulin dimers. Flutax-2 (5/6-mixture) is able to stabilize microtubules of intact T. gallinae and T. foetus trophozoites.
-
GC63596
Fmoc-MMAE
Fmoc-MMAE is a protective group-conjugated monomethyl auristatin E (MMAE), which is a potent tubulin inhibitor. Fmoc-MMAE can be used in the synthesis of ADC.
-
GC12308
Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium
CA4P, Combrestatin A4, CRC 8709
Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium (CA 4DP) is a tubulin destabilizing agent. Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium is the Combretastatin A4 prodrug that selectively targets endothelial cells, induces regression of nascent tumour neovessels, reduces tumour blood flow and causes central tumour necrosis. -
GC74279
Ganoderic acid T-Q
Ganodermic acid T-Q
Ganoderic acid T-Q (Ganodermic acid T-Q) (compound 1) is a natural product that can be found in ganoderma lucidum. -
GC73080
Glembatumumab vedotin
CDX-011; CR011-vcMMAE
Glembatumumab vedotin (CDX-011) is an ADC comprising a fully human IgG2 monoclonal antibody (CR011) directed against glycoprotein NMB and conjugated to the cytotoxic agent MMAE via a protease-sensitive vc linker.